Although iNOS has been detected in a variety of cancers—including colorectal, breast, lung, and melanoma—its prognostic significance remains controversial (Ekmekcioglu et al., 2006; Ramírez-Patiño et al., 2022; Sahebnasagh et al., 2022). Here, NOS2 is linked to melanoma.